Heparin-Conjugated ACE2-Bearing Extracellular Vesicles As Engineered Dual-Decoy for Combating the SARS-CoV-2 Omicron Variant via Pulmonary Delivery
Abstract
Research context
OpenAlex topics: Extracellular vesicles in disease · SARS-CoV-2 and COVID-19 Research · MXene and MAX Phase Materials
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
University of Chinese Academy of Sciences, Beijing 100049, China
Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Zhongshan 528437, China
Artemisinin Research Center, Guangzhou University of Chinese Medicine, Guangzhou 510405, China
Experimental Teaching Center, Guangxi University of Chinese Medicine, Nanning 530200, China
School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, China
School of Life Science, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou, Zhejiang 310024, China
Laboratory Animal Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
Institute of Bioorganic Chemistry, Uzbekistan Academy of Sciences, 83 M. Ulughbek Street, Tashkent 100125, Uzbekistan
NMPA Key Laboratory for Quality Research and Evaluation of Pharmaceutical Excipients, Shanghai 201203, China
Funding
Guangdong Provincial Department of Science and Technology · Zhongshan Science and Technology Bureau · Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences · National Key Research and Development Program of China · Sanofi · Youth Innovation Promotion Association of the Chinese Academy of Sciences · National Natural Science Foundation of China